Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation

By              

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 439-445

Spandidos Publications

Access to resources Recommend Favorite

A case–control study of non-alcoholic fatty liver disease in breast cancer

By Bilici Ahmet   Ozguroglu Mustafa   Mihmanlı İsmail   Turna Hande   Adaletli İbrahim  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 367-371

Humana Press, Inc

Access to resources Recommend Favorite

Association between metabolic syndrome and the development of non-alcoholic fatty liver disease

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 77-84

Spandidos Publications

Access to resources Recommend Favorite

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism

By                    

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-01 ,pp. : 729-733

Spandidos Publications

Access to resources Recommend Favorite

Effects of glutamine on oxidative stress and nuclear factorκB expression in the livers of rats with nonalcoholic fatty liver disease

By            

Experimental and Therapeutic Medicine, Vol. 7, Iss. 2, 2014-01 ,pp. : 365-370

Spandidos Publications

Access to resources Recommend Favorite